Early screening for type 1 diabetes in vulnerable children gains new support amid concerns over costs and benefits

A recent JAMA study highlights the potential benefits of early detection of presymptomatic type 1 diabetes in children, especially those with developmental conditions, prompting calls for expanded screening despite cost concerns.

A new JAMA study has strengthened the case for finding type 1 diabetes before symptoms appear in children. Christiane Winkler and colleagues reported that roughly 0.03% of children in their German sample had presymptomatic type 1 diabetes, and that nearly one in 10 of those children later went on to develop the clinical form of the disease. The researchers said their screening method identified more than 80% of the cases they found.

The findings matter beyond diabetes specialists because some children with developmental conditions appear to carry a higher burden of cardiometabolic illness. A systematic review and meta-analysis in JAMA Pediatrics found that people with autism spectrum disorders face a higher risk of diabetes and related conditions, while an accompanying commentary argued that children with autism deserve closer health monitoring. Other research cited in the same debate has also linked Down syndrome and intellectual disability with a greater prevalence of diabetes and other long-term health problems.

That context has led some clinicians and commentators to argue that screening may be especially useful for children who are already medically vulnerable. In the JAMA editorial on Winkler’s study, Shweta Mital, Michael J. Haller and Desmond A. Schatz said screening should be broadened beyond genetically selected groups to improve early detection and treatment. In their reply, Ezio Bonifacio, Winkler and Anette G. Ziegler said costs still need careful scrutiny, pointing to Canadian research suggesting that wider screening could cost more than it saves, even if it reduces episodes of diabetic ketoacidosis.

For parents and educators, the practical point is less about classroom teaching than about wider child welfare. Children with disabilities may not be the most obvious group for diabetes outreach, but the overlap between developmental conditions and chronic disease risk suggests that screening conversations could be worthwhile. If a child is found to be in an early stage of type 1 diabetes, regular follow-up may help track progression and open the door to earlier intervention.